Richard D’Souza

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi, Roland E. Schmieder, Felix Mahfoud et al. · The Lancet · 2018 · 716 citations · Full text

Medicine, Cardiology, Nephrology +14

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Michael Böhm, Kazuomi Kario, David E. Kandzari et al. · The Lancet · 2020 · 587 citations

Medicine, Cardiology, Nephrology +8

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi, Kintur Sanghvi, Manish Saxena et al. · The Lancet · 2021 · 416 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +12

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Bryan Williams, Thomas M. MacDonald, S. V. Morant et al. · The Lancet Diabetes & Endocrinology · 2018 · 331 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

Felix Mahfoud, David E. Kandzari, Kazuomi Kario et al. · The Lancet · 2022 · 282 citations · Full text

Medicine, Cardiology, Nephrology +11